Developing new medical devices for children
Official title: UCSF-Stanford Pediatric Device Consortium
Funded at University of California, San Francisco · NIH-10922814 · Data updated 2026-11-12
This study is all about making new medical devices that are safe and effective for kids, so they can get the care they need more easily and quickly.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $1,483,334 |
| NIH project number | 5P50FD007967-02 |
| Project ID | NIH-10922814 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children who require medical devices specifically designed for their age and size.
✕Less likely to help
Patients who are adults or those who do not require pediatric-specific medical devices may not benefit from this research.
What this research studies
The UCSF-Stanford Pediatric Device Consortium focuses on creating innovative medical devices specifically designed for the unique needs of children. This initiative supports various stages of device development, including research, testing, and commercialization, ensuring that new technologies are safe and effective for pediatric patients. By leveraging real-world clinical data, the consortium aims to expedite the regulatory process for these devices, ultimately improving access for children in need. The collaboration between two leading universities and children's hospitals enhances the potential for impactful innovations.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer and more effective medical devices tailored for pediatric patients.
How similar studies have gone: Previous initiatives in pediatric device innovation have shown success, with over 250 projects supported and several products already available on the market.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Lee, Hanmin — University of California, San Francisco
- Study coordinator: Lee, Hanmin
Related research
Other NIH-funded projects on the same topics.
-
How cancer cells use exosomes to evade the immune system
This study is looking at how cancer cells use tiny bubbles called exosomes to hide proteins that can keep your immune system from fighting the tumor, and by figuring this out, the researchers hope to help doctors understand why some people respond well to cancer treatments while others don’t, ultimately aiming to creat
-
Reducing harm from smoking using electronic cigarettes
This study is looking at whether using electronic cigarettes can be a safer option for people who smoke traditional cigarettes, by comparing the health effects and exposure to harmful substances between the two.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Cutaneous opioid signals in skin inflammation
A mentor-identified clinician-researcher at UCSF is studying how natural skin opioids regulate itch and pain in inflammatory skin conditions like eczema and hidradenitis, with plans to map where these opioids come from and how they affect skin nerves.
-
Pooling international data to understand long-term bisphosphonate use and atypical femur fractures
This project combines large patient datasets from multiple countries to understand how long-term bisphosphonate use relates to rare hip and thigh bone fractures, helping doctors and patients make safer treatment choices.
-
Airway cell and immune cell talks in lung transplant failure
This grant tests how airway cells and immune cells interact to drive chronic rejection after lung transplant, with the goal of slowing or preventing scar-like damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.